AC Immune (ACIU) Loans - Net (2018 - 2019)
AC Immune's (ACIU) quarterly Loans - Net came in at $101495.1 in Q3 2019, up 103746.03% on a QoQ basis from $97.74 in Q2 2019.
AC Immune (ACIU) Loans - Net (2018 - 2019) Analysis & Trends
AC Immune (ACIU) has 2 years of Loans - Net data on file, last reported at $101495.1 in Q3 2019.
- On a quarterly basis, Loans - Net changed N/A year-over-year to $101495.1 in Q3 2019; TTM through Sep 2019 was $101495.1, a N/A change from a year earlier, with the FY2018 full-year figure at $199962.1, changed N/A from the prior year.
- Loans - Net for Q3 2019 stood at $101495.1, up from $97.74 in the prior quarter.
- Over the last five years, Loans - Net for ACIU reached as high as $201816.6 in Q1 2019 and fell as low as $97.74 in Q2 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Loans - Net (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | AC Immune | 225.68 Mn | 225.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 101,495.14 |
| Sep 30, 2019 | 101,495.14 |
| Jun 30, 2019 | 97.74 |
| Jun 30, 2019 | 97.74 |
| Mar 31, 2019 | 201,816.57 |
| Mar 31, 2019 | 201,816.57 |
| Dec 31, 2018 | 199,962.12 |
| Dec 31, 2018 | 199,962.12 |